Q&A

Oral vitamin D3 decreases fracture risk in the elderly

Author and Disclosure Information

  • BACKGROUND: Previous studies have shown that daily supplementation with vitamin D3 (800 IU) and calcium decreases the incidence of fractures; however, conflicting data exist as to whether vitamin D3 alone has the same effect. Observational studies suggest that vitamin D may increase the incidence of cancer and cardiovascular disease.
  • POPULATION STUDIED: This British study invited 9582 doctors from the Clinical Trials Studies Unit in Oxford and 1538 patients from a general practice in Ipswich, Suffolk, aged 65 to 85 years, to participate.
  • STUDY DESIGN AND VALIDITY: After age, sex, and patient/physician stratification, subjects were randomly assigned to receive identical-appearing pills of vitamin D3 (100,000 IU) or placebo, which were mailed to them every 4 months for 5 years. Patients mailed back a card to confirm compliance and to report health and falls.
  • OUTCOMES MEASURED: The primary outcome was any fracture as assessed by self-report or death certificate. Secondary outcomes included self-reported health and falls, cardiovascular and cancer incidence and mortality, and all-cause mortality.
  • RESULTS: Compliance was similar among the physician and patient groups and between the placebo and vitamin D groups; fracture rates were similar among the physician and patient groups. Average calcium intake was similar.


 

PRACTICE RECOMMENDATIONS

Vitamin D3 (or its physiologic equivalent, ergocalciferol), administered at a dose of 100,000 IU every 4 months for 5 years, is effective for primary prevention of fractures in the active elderly aged 65 to 85 years.

This treatment regimen has no effect on cardiovascular, cancer, or all-cause mortality. Despite a seemingly large dose averaging 800 IU per day, this regimen is a safe, cheap (<$2 per year), and effective therapy for primary prevention of fractures.

Recommended Reading

Can high-dose supplementation with vitamins C and E, beta carotene, and zinc slow the progression of macular degeneration?
MDedge Family Medicine
Ginkgo is not a smart pill
MDedge Family Medicine
Screening for handicapping hearing loss in the elderly
MDedge Family Medicine
Improving influenza vaccination rates in the elderly
MDedge Family Medicine
Does a hip protector reduce the risk of hip fracture in frail elderly patients?
MDedge Family Medicine
Clinical Findings Associated with Radiographic Pneumonia in Nursing Home Residents
MDedge Family Medicine
Should we treat elevated cholesterol in elderly patients?
MDedge Family Medicine
Vitamin E may worsen acute respiratory tract infections in the elderly
MDedge Family Medicine
What are the indications for urodynamic testing in older adults with incontinence?
MDedge Family Medicine
Six-item screening tool is sensitive for dementia
MDedge Family Medicine